Viatris (VTRS) Change in Receivables (2020 - 2026)

Viatris' (VTRS) quarterly Change in Receivables came in at $126.3 million in Q1 2026, up 175.18% year-on-year from $45.9 million in Q1 2025, and up 146.45% quarter-over-quarter from -$271.9 million in Q4 2025.

Viatris (VTRS) Change in Receivables (2020 - 2026) Analysis & Trends

Viatris' Change in Receivables history runs 7 years deep, the most recent figure standing at $126.3 million for Q1 2026.

  • On a quarterly basis, Change in Receivables rose 175.18% year-over-year to $126.3 million in Q1 2026; TTM through Mar 2026 was -$40.3 million, a 91.21% increase from a year earlier, with the FY2025 full-year figure at -$334.6 million, down 11.5% from the prior year.
  • Change in Receivables improved to $126.3 million in Q1 2026 per VTRS's latest filing, from -$271.9 million in the prior quarter.
  • Across five years, Change in Receivables topped out at $339.2 million in Q4 2022 and bottomed at -$300.5 million in Q4 2024.
  • The 5-year median for Change in Receivables is $9.6 million (2025), against an average of -$20.4 million.
  • Across the five-year window, Change in Receivables jumped 3361.22% in 2022 and sank 1614.29% in 2025, its largest moves.
  • Year by year, Change in Receivables stood at $339.2 million in 2022, then slumped by 124.0% to -$81.4 million in 2023, then plunged by 269.16% to -$300.5 million in 2024, then increased by 9.52% to -$271.9 million in 2025, then surged by 146.45% to $126.3 million in 2026.
  • Per Business Quant, the three latest VTRS Change in Receivables figures stand at $126.3 million (Q1 2026), -$271.9 million (Q4 2025), and $95.7 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Receivables (Qtr)
1 Haleon 88.07 Bn 86.20 Bn - -
2 Teva Pharmaceutical Industries 35.75 Bn 32.01 Bn 1.97 Bn -78.00 Mn
3 Zoetis 31.84 Bn 29.90 Bn 1.62 Bn 106.00 Mn
4 Takeda Pharmaceutical 27.18 Bn 23.12 Bn 4.39 Bn -621.82 Mn
5 United Therapeutics 23.09 Bn 20.93 Bn 648.10 Mn -38.20 Mn
6 RedHill Biopharma 21.32 Bn 21.32 Bn - -
7 Viatris 19.96 Bn 18.16 Bn 1.16 Bn 126.30 Mn
8 Neurocrine Biosciences 17.66 Bn 16.34 Bn 800.70 Mn 81.40 Mn
9 Elanco Animal Health 12.44 Bn 12.02 Bn 785.00 Mn -
10 Vireo Growth 10.53 Bn 10.38 Bn 59.30 Mn 1.10 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 126.30 Mn
Mar 31, 2026 126.30 Mn
Dec 31, 2025 -271.90 Mn
Dec 31, 2025 -271.90 Mn
Sep 30, 2025 95.70 Mn
Sep 30, 2025 95.70 Mn
Jun 30, 2025 9.60 Mn
Jun 30, 2025 9.60 Mn
Mar 31, 2025 -168.00 Mn
Mar 31, 2025 -168.00 Mn
Dec 31, 2024 -300.50 Mn
Dec 31, 2024 -300.50 Mn
Sep 30, 2024 33.00 Mn
Sep 30, 2024 33.00 Mn
Jun 30, 2024 -22.80 Mn
Jun 30, 2024 -22.80 Mn
Mar 31, 2024 -9.80 Mn
Mar 31, 2024 -9.80 Mn
Dec 31, 2023 -81.40 Mn
Dec 31, 2023 -81.40 Mn